Literature DB >> 20338113

A clinical evaluation of bioresorbable staples for mucoperichondrial flap coaptation in septoplasty.

Thomas A Tami1, Ronald B Kuppersmith, James Atkins.   

Abstract

BACKGROUND: During septoplasty surgery, the formation of dead space between the mucosal flaps must be minimized to prevent septal hematoma and promote healing. Historically, this has been achieved by using techniques such as nasal packing or the continuous septal quilting or whip suturing. This study presents the first clinical results using a septal stapling device that uses bioresorbable staples to achieve mucoperichondrial flap coaptation during septoplasty.
METHODS: The septal stapler was used in 24 subjects. The primary outcome measure was whether septal coaptation was accomplished 1 week postoperatively. The extent of tissue reaction at the site of staple placement was also evaluated.
RESULTS: In all subjects, coaptation with septal staples was successfully accomplished with no septal hematoma formation. At 1 week follow-up, there was either no (79%) or minimal (21%) tissue reaction at the site of staple placement.
CONCLUSION: The use of bioresorbable staples appears to be a safe, efficient, and effective alternative to other methods used for mucoperichondrial flap coaptation in septoplasty surgery.

Entities:  

Mesh:

Year:  2010        PMID: 20338113     DOI: 10.2500/ajra.2010.24.3438

Source DB:  PubMed          Journal:  Am J Rhinol Allergy        ISSN: 1945-8932            Impact factor:   2.467


  2 in total

1.  Nasal silicone splints and quilting sutures using a septum stitch device following septoplasty: a prospective comparative study.

Authors:  Akihito Kuboki; Shun Kikuchi; Daiya Asaka; Nobuto Onda; Tsuguhisa Nakayama; Hiromi Kojima; Nobuyoshi Otori
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-05-23       Impact factor: 2.503

2.  Septal stapler use during septum surgery.

Authors:  Güven Yildirim; Cemal Cingi; Ercan Kaya
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-08-28       Impact factor: 2.503

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.